MELANIE MABRY: Open Payments
NPI 1710525720 · BENTON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 33 payments from 9 companies in 2025. Trend: 2023 $328 · 2024 $302 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $177 |
| AstraZeneca Pharmaceuticals LP | 7 | $138 |
| PFIZER INC. | 6 | $119 |
| Dexcom, Inc. | 4 | $77 |
| Novo Nordisk Inc | 2 | $30 |
| Alkermes, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Amgen Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: UBRELVY, NURTEC ODT, QULIPTA, BREZTRI, Dexcom G6 Transmitter, AIRSUPRA, PREVNAR 20, Rybelsus.
Industry payments across AR — which companies pay providers there.
